We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Drugmakers, Biotechs Develop Template Biosimilar Substitution Bill
Generic Drugmakers, Biotechs Develop Template Biosimilar Substitution Bill
Generic drugmakers have joined forces with the biotech industry to craft biosimilar substitution legislation in Washington State. They plan to use the bill as a template for similar drives across the country.